Key Record Dates
ClinicalTrials.gov Identifier: | NCT04702737 |
---|---|
Brief Title: | A Study of Tarlatamab (AMG 757) in Participants With Neuroendocrine Prostate Cancer |
First Submitted : | January 7, 2021 |
First Submitted that Met QC Criteria : | January 7, 2021 |
First Posted : | January 11, 2021 |
Last Update Submitted that Met QC Criteria : | August 11, 2022 |
Last Update Posted : | August 12, 2022 |